Subsidiary drug license suspended for 5 days at Nashik store
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, received an order on July 4, 2026 from the Asst. Commissioner and Licensing Authority, Food and Drug Administration, Nashik, Maharashtra. The drug license of its Samta Nagar Nashik store has been suspended for five days under Rule 65 of the Drugs and Cosmetics Act, 1940. The company estimates a potential revenue loss of about Rs 0.75 lakhs from this suspension. The disclosure is filed under SEBI Listing Regulations.
Minimal financial impact at about Rs 0.75 lakhs revenue loss; isolated regulatory action affecting one store for five days; likely no material effect on stock.